NEXT Biotech (BIOTK)

That's all fine and dandy, but I still haven't seen one working modulator. I know there's wafers supposedly in the fab right now but they still have to be tested and qualified. Then there's the contracts, licensing, etc. It's going to take a year or more. Other applications are years away but

I'M NOT HERE TO ATTACK ANYONE , JUST TRYING TO UNDERSTAND THE CO TWEET/NEWS ... PLEASE NO HARD FEELINGS HERE , WE ALL HERE FOR SUCCESS .. >> I'M NOT SELLING

99% of the lawyers make a bad name for the rest. I fear they will BK $AVXL.

These ppl, they just ignore facts. The question is, who has the higher number...the number of ignored facts or the number of AI hallucinations? They're both pretty high. They deserve ea other 🤣

Yes and then he let it die along with HMLA. Killed them both. Oh this could be the perfect example of everything happens for a reason…100x better here

3% ⬇️ today

I like the remand point but then what are we reversing
So i reverse the circuit judge and disagree with him on the passive inducement méritos
Then the case is remanded to a Judge that has already dismissed
Then do you think we can automatically reopen a trial that was dismissed?

There’s a reason why this is at the bottom. But Marshall will call you delusional and tell you to sell (into his bid)

should have slapped .007 this morning-- IMO.

Been living in the dark

www.youtube.com/watch?v=sibgdsPP5lg For far too long

https://www.youtube.com/watch?v=sibgdsPP5lg
Be ready

Where do you see $3M?

Or do us a solid and just transfer the rights over for free after getting several million a year for how long now? But get it resolved some which way. 

He stands to make way more with a pop in ELTP’s share price than by any other move, can’t convin

Buckle up. I hope these clowns were smart enough to deploy cash for the purchase of the buildings.

QH................................a/h

Galzus Research,

The two hallmarks of drug regulation are determining safety and efficacy before commercial scale use by doctors and patients. Being able to kill cancer cells is fairly easy in the lab. Killing cancer cells without terrible side effects in people is very difficult fo

Origin Materials Reaffirms Intention to Voluntarily Delist from Nasdaq and Deregister with SECJune 10, 2026 4:01 PM
Business Wire

Alaska Airlines teams up with Seattle FIFA World Cup 2026™ Local Organizing Committee to launch a new aircraft livery celebrating summer soccer in SeattleJune 10, 2026 4:00 PM
PR Newswire (US) Alaska's latest livery acts as a tribute to S

Kewaunee Scientific to Report Results for Fiscal Year and Fourth QuarterJune 10, 2026 4:02 PM
PR Newswire (US) class="legendSpanClass"STATESVILLE, N.C., class="legendSpanClass"June 10, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of DirectorsJune 10, 2026 4:05 PM
Business Wire Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effe

DAIC 🧨 next 500% 🤷‍♂️🛩️ let’s 🙏

These MM have no shame - I have to believe they don't own a mirror. Watching them constantly manipulating this stock is sickening - especially at the end. The chart doesn't lie.

Figma to Host Investor and Analyst Session at Config 2026June 10, 2026 4:05 PM
Business WireFigma, Inc. (NYSE: FIG), a leading design and product development platform, today announced it will host an Investor and Analyst Session at Config 2026 on Wednesday, June 24, 2026 at 2:0

🌐$ 1,018,006 dollar vol 6/10
$ 1,004,838 dollar vol 6/9
$ 1,424,498 dollar vol 6/8
$ 903,484 dollar vol 6/5 1% loss for the week
$ 298,882 dollar vol 6/4
$ 641,423 dollar vol 6/3
$ 1,115,588 dollar vol 6/2
$ 919,309 dollar vol 6/1
$ 877

B&G Foods Closes $475 Million Private Offering of Senior Notes due 2031June 10, 2026 4:05 PM
Business Wire B&G Foods, Inc. (NYSE: BGS) announced today that it has completed its previously announced offering of $475.0 million aggregate principal amount of 11.00% senior notes due

H.B. Fuller to Report Second Quarter 2026 Results on June 24, 2026June 10, 2026 4:05 PM
Business Wire H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended May 30, 2026, in a press release issued after the market

Stitch Fix Announces Third Quarter of Fiscal 2026 Financial ResultsJune 10, 2026 4:05 PM
Business Wire Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced its financial results for the third quarter of fiscal 2026 ended May 2, 2026.